Predicting Immunological Risk for Stage 1 and Stage 2 Diabetes Using a 1-Week CGM Home Test, Nocturnal Glucose Increments, and Standardized Liquid Mixed Meal Breakfasts, with Classification Enhanced by Machine Learning

Diabetes Technology&Therapeutics, Ahead of Print.

Source: Diabetes Technology and Therapeutics - June 15, 2023 Category: Endocrinology Authors: Eslam Montaser Marc D. Breton Sue A. Brown Mark D. DeBoer Boris Kovatchev Leon S. Farhy Source Type: research